journal
Journals ClinicoEconomics and Outcomes ...

ClinicoEconomics and Outcomes Research : CEOR

https://read.qxmd.com/read/36923468/teachers-willingness-to-pay-for-social-health-insurance-and-its-determinant-factors-at-harar-region-ethiopia-2021
#1
JOURNAL ARTICLE
Sintayehu Girma, Gizachew Abebe, Aklilu Tamire, Hamdi Fekredin, Bedasa Taye
BACKGROUND: Most developing nations lag behind in maintaining their populations' health. These nations are characterized by under-financing, low health cost protection mechanisms for the poor, and lack of risk pooling and cost sharing methods. To tackle this challenge, Ethiopia proposed social health insurance in 2010 even though its implementation was delayed. Hence, the purpose of this study was to assess teachers' willingness to pay for the newly proposed social health insurance and its associated factors...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36919083/glucarpidase-for-treating-adults-with-delayed-methotrexate-elimination-due-to-impaired-renal-function-an-economic-simulation-analysis
#2
JOURNAL ARTICLE
Jaya Kala, Rebecca Nelson, Christopher Drudge, Allen Zhou, Suzanne Ward, Megan Bourque
BACKGROUND: Glucarpidase is indicated for treating delayed methotrexate (MTX) elimination due to impaired renal function. Although glucarpidase is capable of rapidly eliminating MTX independent of renal clearance, its cost can be perceived as a barrier to use. However, no published economic analyses have evaluated glucarpidase relative to comparable treatments. PURPOSE: To assess the economic value of glucarpidase for treating adult patients in the United States (US) who experience delayed MTX elimination due to impaired renal function...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36883115/comprehensive-custom-pak-%C3%A2-in-cataract-and-vitreoretinal-surgery-in-canadian-hospitals-time-and-budget-impact-analysis
#3
JOURNAL ARTICLE
Donna Punch, Jonathan S Davis, Rebecca Hahn, Rav Gill, Chia-Wen Hsiao, Richard Kara
PURPOSE: Surgical procedure packs are commonly used in ophthalmological surgeries, but quantitative evidence demonstrating the time efficiency and economic impact of their use is limited. Evaluating the time and cost of surgical pack use is particularly important for publicly funded healthcare systems with tight budgets and/or an emphasis on value-based care. This study sought to estimate the economic impact of comprehensive surgical pack use in cataract and vitreoretinal (retina) surgeries across operating room (OR), materials management, and accounting departments in Canada...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36875284/descriptive-epidemiology-and-outcomes-of-patients-with-short-stay-hospitalizations-for-the-treatment-of-congestive-heart-failure-in-the-us
#4
JOURNAL ARTICLE
Marya D Zilberberg, Brian H Nathanson, Katherine Sulham, John F Mohr, Matthew M Goodwin, Andrew F Shorr
BACKGROUND: Congestive heart failure (CHF) hospitalizations cost the US $35 billion annually. Two-thirds of these admissions, generally requiring </=3 days in the hospital, are solely for the purpose of diuresis, and may be avoidable. METHODS: Among patients discharged with CHF as the principal diagnosis (PD), we compared characteristics and outcomes between those with hospital length of stay (LOS) </=3 days (short, SLOS) and >3 days (long, LLOS) in a cross-sectional multicenter analysis within the 2018 National Inpatient Sample...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36855751/infrared-thermography-compared-to-standard-care-in-the-prevention-and-care-of-diabetic-foot-a-cost-analysis-utilizing-real-world-data-and-an-expert-panel
#5
JOURNAL ARTICLE
Olli Kurkela, Jorma Lahtela, Martti Arffman, Leena Forma
AIM: Infrared thermography (IRT) is a non-invasive technology for screening and early detection of diabetic foot. Real-world data and the Delphi technique were used to assess IRT's potential effect on typical care pathways of diabetic foot and their costs in the Finnish healthcare setting. METHODS: The most typical care pathways of diabetic foot were identified from national healthcare registers from 2011 to 2017. The effect of IRT in terms of avoidable care episodes was assessed by a Delphi panel including Finnish diabetic foot specialists (n=13)...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36855750/systematic-literature-review-of-real-world-evidence-on-dose-escalation-and-treatment-switching-in-ulcerative-colitis
#6
REVIEW
Harpreet Singh, Liam Wilson, Tom Tencer, Jinender Kumar
BACKGROUND: Currently approved biologic therapies for moderate-to-severe ulcerative colitis have well-established efficacy. However, many patients fail to respond or lose response, leading to dose escalation or treatment switching. OBJECTIVE: We sought to identify real-world evidence on dose escalation and treatment switching and associated clinical and economic outcomes among adults with ulcerative colitis treated with infliximab, adalimumab, golimumab, vedolizumab, ustekinumab, or tofacitinib...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36825076/celestia-cost-effectiveness-analysis-of-empagliflozin-versus-sitagliptin-in-patients-with-type-2-diabetes-in-greece
#7
JOURNAL ARTICLE
Gianni Ghetti, Lorenzo Pradelli, Giannis Papageorgiou, George Karpouzos, Yelda Arikan
PURPOSE: Globally, the prevalence of diabetes is on the rise, with the number of affected individuals predicted to cross 700 million by 2045. In Greece, in 2015, almost 700,000 people received prescribed medication for type 2 diabetes. The CELESTIA study aims to assess the cost-effectiveness of empagliflozin compared to branded sitagliptin in type 2 diabetes patients both with and without established cardiovascular disease in Greece from a third payer perspective. METHODS: The IQVIA Core Diabetes Model was used and analyses were conducted from the Greek healthcare payer perspective...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36778040/evaluating-the-clinical-and-economic-outcomes-associated-with-poor-glycemic-control-in-people-with-type-1-diabetes-in-the-netherlands
#8
JOURNAL ARTICLE
Robert Gerald Jan Moes, Eline L Huisman, Samuel J P Malkin, Barnaby Hunt
INTRODUCTION: Achieving and maintaining glycemic control is the cornerstone of type 1 diabetes management, with the aim of reducing the incidence of diabetes-related complications over the long term. However, many individuals fail to reach glycemic targets. The present study evaluated the clinical and economic burden associated with poor glycemic control in people with type 1 diabetes in the Netherlands, and the improvements in outcomes that can be achieved by improving treatment. METHODS: Immediate glycemic control, defined as achieving a glycated hemoglobin (HbA1c) target of 7...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36761408/a-cost-utility-analysis-of-sq-%C3%A2-tree-slit-tablet-versus-placebo-in-the-treatment-of-birch-pollen-allergic-rhinitis-from-a-swedish-societal-perspective
#9
JOURNAL ARTICLE
Richard F Pollock, Andreas K Slættanes, Henrik Brandi, Tobias Sydendal Grand
BACKGROUND AND AIMS: Allergic rhinitis (AR) is an immunoglobulin E antibody-mediated inflammatory condition that arises in response to inhaled allergens such as pollen. Pollens from trees in the birch homologous group are the most common allergenic tree pollens in Northern and Central Europe and North America. SQ® Tree SLIT-Tablet (ITULAZAX®) is a sublingual immunotherapy tablet indicated for moderate-to-severe AR and/or conjunctivitis induced by pollen from the birch homologous group...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36747496/the-high-cost-of-death-after-acute-myocardial-infarctions-results-from-a-national-us-hospital-database
#10
JOURNAL ARTICLE
Peter J Mallow, Frederick Browne, Kamal Shemisa
INTRODUCTION: This study described the differences in costs and length of stay (LOS) among patients with AMI who died versus survived using a large, nationally representative cohort of AMI patients. METHODS: The 2019 HCUP NIS was used to analyze costs, and LOS among all patients with a principal diagnosis of AMI. A propensity-score matched analysis and multivariable regression were used to adjust for patient and hospital characteristics. RESULTS: There were 4559 visits in each of the cohorts (total 9118)...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36726966/the-relative-value-of-anti-obesity-medications-compared-to-similar-therapies
#11
JOURNAL ARTICLE
Nina Kim, Joaquin Estrada, Isabella Chow, Aleksandrina Ruseva, Abhilasha Ramasamy, Chakkarin Burudpakdee, Christopher M Blanchette
PURPOSE: To demonstrate a need for improved health insurance coverage for anti-obesity medications (AOMs) by comparing clinical and economic benefits of obesity treatments to covered medications for selected therapeutic areas. METHODS: Using a grey literature search, we identified and prioritized therapeutic areas and treatment analogues for comparison to obesity. A targeted literature review identified clinical and economic outcomes research across the therapeutic area analogues...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36700053/impact-of-implementing-key-performance-indicators-on-catheter-associated-urinary-tract-infection-cauti-rates-among-adult-icu-patients-in-saudi-arabia
#12
JOURNAL ARTICLE
Nouf Alhabdan, Asma Alyaemni, Mohammed M Aljuaid, Ali Baydoun, Samer Hamidi
BACKGROUND: The prevalence of catheter-associated urinary tract infections (CAUTIs) in hospitals characterizes one of the most significant problems in healthcare. This study aims to assess whether the implementation of impact of key performance indicators (KPIs) checklist reduces the number of CAUTI in adults present in intensive care unit (ICU) with indwelling catheters. METHODS: This is a retrospective analytical study conducted in a tertiary hospital in Riyadh, Saudi Arabia, from June 2020 to June 2021...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36687800/elicitation-of-health-state-utility-values-in-retinitis-pigmentosa-by-time-trade-off-in-the-united-kingdom
#13
JOURNAL ARTICLE
Paul O'Brien, Ashley Enstone, Daisy Bridge, Robin Wyn, Judit Banhazi
INTRODUCTION: Retinitis pigmentosa (RP) is an inherited retinal pathology associated with "night blindness" and progressive loss of peripheral vision, in some cases leading to complete blindness. Health state utility values are required for activities such as modelling disease burden or the cost-effectiveness of new interventions. The current study aimed to generate utility values for health states of varying levels of functional vision in RP, with members of the general public in the UK...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36660476/epilepsy-related-direct-medical-and-direct-non-medical-cost-in-adult-patients-living-with-epilepsy-at-a-tertiary-neurology-center-in-rwanda
#14
JOURNAL ARTICLE
Dirk E Teuwen, Fidele Sebera, Alphonsine Murekeyiteto, Ieme Garrez, Eduardo Sanchez-Iriso, Josiane Umwiringirwa, Georgette Umuhoza, Paul A J M Boon, Peter Dedeken
OBJECTIVE: Up to one in four patients living with epilepsy (PwE) mentions financial constraints as a reason for loss to follow-up at the Ndera tertiary neuropsychiatry hospital. Therefore, we evaluated the annual direct medical cost (DMC) and direct non-medical cost (DnMC) of epilepsy and calculated costs assuming different follow-up frequency. MATERIALS AND METHODS: DMC data were obtained from a descriptive retrospective study of medical records, pharmacy dispensation and hospital logs of PwE, following their initial consultation in 2018 and who adhered to the normal clinical practice of monthly consultations for one year...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36636485/cost-effectiveness-of-empagliflozin-in-combination-with-standard-care-versus-standard-care-only-in-the-treatment-of-heart-failure-patients-in-finland
#15
JOURNAL ARTICLE
Taru Hallinen, Santtu Kivelä, Erkki Soini, Veli-Pekka Harjola, Mari Pesonen
PURPOSE: Sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin has recently been shown to improve the outcomes of heart failure (HF) patients regardless of patient's left ventricular ejection fraction by reducing the combined risk of cardiovascular death or hospitalization for worsening HF. The aim of this study was to assess the cost-effectiveness of adding empagliflozin to the standard care (SC) in comparison to SC only in the treatment of HF in Finland. PATIENTS AND METHODS: The assessment was performed in the cost-utility framework using two Markov cohort state-transition models, one for HF with reduced ejection fraction (HFrEF) and one for HF with preserved ejection fraction (HFpEF)...
2023: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36578311/medication-adherence-and-healthcare-utilization-in-relapsing-remitting-multiple-sclerosis-patients-using-teriflunomide
#16
JOURNAL ARTICLE
Nupur Greene, Keiko Higuchi, Katalin Bognar, Eunice Chang, Michael S Broder
PURPOSE: Multiple sclerosis (MS) is a costly, immune-mediated disease of the central nervous system. Most patients have relapsing-remitting MS (RRMS) for which disease-modifying therapies (DMTs) provide an effective treatment option by reducing relapse rates. However, adherence to DMTs is suboptimal. This study examines the association between adherence to teriflunomide and clinical and healthcare utilization outcomes. PATIENTS AND METHODS: Patients with RRMS who started treatment with teriflunomide between 1/1/2018 and 12/31/2019 were analyzed using IQVIA PharMetrics® Plus data...
2022: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36569430/the-burden-of-a-multiple-myeloma-diagnosis-on-patients-and-caregivers-in-the-first-year-western-european-findings
#17
JOURNAL ARTICLE
Xenia Gatopoulou, Wafae Iraqi, Kate Morgan, Kawitha Helme, Victoria A Spain, Jennifer Redfearn, Brett Gardiner
BACKGROUND: This research aimed to quantify the burden of illness (BoI) in transplant eligible (TE) and transplant non-eligible (TNE) newly diagnosed multiple myeloma (NDMM) patients and their caregivers, in the first year after diagnosis: at months 0, 3, and 12. METHODS: Prospective, cross-sectional, observational NDMM study of TE and TNE patients and their caregivers from France, Germany, Italy, and Spain was conducted between May 2019 and January 2021. A structured, online questionnaire measuring disease burden, direct and costs, out-of-pocket expenses, and health-related quality of life (HRQoL) was used...
2022: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36389103/economic-impact-analysis-of-custom-pak-%C3%A2-on-cataract-and-vitreoretinal-surgery-in-the-united-states
#18
JOURNAL ARTICLE
Brandon D Ayres, Omesh P Gupta, Jonathan S Davis, Rebecca Hahn, Chia-Wen Hsiao, Richard Kara, Sandro Di Simplicio
Purpose: Implicit costs of surgical preparation and materials management for cataract/anterior segment and retinal/posterior segment procedures are often unquantified. Use of ophthalmological surgical procedure packs is common in these surgeries; however, there is little in the literature demonstrating their time and cost impacts. Understanding the costs and potential benefits of surgical pack procedure use is important for administrators in purchasing decision-making. The objective of this study is to estimate the economic impact of Alcon Custom Pak® on cataract and vitreoretinal (retina) surgery in hospitals and ambulatory surgical centers (ASCs) across operating room (OR), materials management, and accounting departments...
2022: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36389102/surgical-complication-risk-factor-identification-using-high-dimensional-hospital-data-an-illustrative-example-in-hemostasis-related-complications
#19
JOURNAL ARTICLE
Stephen Johnston, Aakash Jha, Sanjoy Roy, Esther Pollack
Purpose: To describe an approach wherein high-dimensional hospital data can be used to identify generalizable risk factors for surgical complications for which there may be limited prior knowledge, as illustrated in the context of hemostasis-related complications (HRC). Patients and Methods: This was a retrospective study of the Premier Healthcare Database. Patients included for the study underwent video-assisted thoracoscopic lobectomy (VATL), laparoscopic right colectomy (LRC), or laparoscopic sleeve gastrectomy (LSG) on an inpatient setting between Oct-2015 and Feb-2020 (first = index)...
2022: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/36389101/the-long-term-healthcare-utilization-and-economic-burden-of-rsv-infection-in-children-%C3%A2-5-years-in-japan-propensity-score-matched-cohort-study
#20
JOURNAL ARTICLE
Viktor Chirikov, Marc Botteman, Eric A F Simões
BACKGROUND: The objective of this study was to estimate the long-term healthcare utilization and cost burden of RSV by chronological age of diagnosis (Year 1, Year 2 and Years 3-5 cohorts) as well as by gestational age at birth in Japan. METHODS: The JMDC database was used to retrospectively identify RSV and control patients between February 1, 2011 and January 31, 2016 and follow them through December 31, 2017. Infants with RSV infection (n = 9028 in Year 1; n = 4929 in Year 2; n = 2004 in Years 3-5) were matched to controls (n = 17,886; n = 9351; n = 3655, respectively) based on gestational age and year and quarter of birth; controls were assigned the index date (ie, diagnosis) of their respective match...
2022: ClinicoEconomics and Outcomes Research: CEOR
journal
journal
43575
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.